Search research articles
Contact Us
Filters
Showing results (81-90 of 172) with videos related to
Page
of 18
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
June 25, 2009
BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma
Masumichi Saito, Urban Novak, Erich Piovan, et al.
Blood
|
March 31, 2021
Synergistic efficacy of the dual PI3K-δ/γ inhibitor duvelisib with the Bcl-2 inhibitor venetoclax in Richter syndrome PDX models
Andrea Iannello, Nicoletta Vitale, Silvia Coma, et al.
Blood
|
April 2, 2015
The tumor virus landscape of AIDS-related lymphomas
Aaron Arvey, Akinyemi I Ojesina, Chandra Sekhar Pedamallu, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
September 17, 2020
Autopsy Findings in 32 Patients with COVID-19: A Single-Institution Experience
Sarah S Elsoukkary, Maria Mostyka, Alicia Dillard, et al.
Immunity
|
June 16, 2007
Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL
Bing He, Weifeng Xu, Paul A Santini, et al.
The Journal of Experimental Medicine
|
June 3, 2009
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
Till Strowig, Cagan Gurer, Alexander Ploss, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 1, 2010
Response to second-line therapy defines the potential for cure in patients with recurrent diffuse large B-cell lymphoma: implications for the development of novel therapeutic strategies
Rebecca L Elstrom, Peter Martin, Katya Ostrow, et al.
The Journal of Biological Chemistry
|
November 19, 2020
Targeted reduction of cholesterol uptake in cholesterol-addicted lymphoma cells blocks turnover of oxidized lipids to cause ferroptosis
Jonathan S Rink, Adam Yuh Lin, Kaylin M McMahon, et al.
Leukemia & Lymphoma
|
February 28, 2007
Dose-attenuated radioimmunotherapy with tositumomab and iodine 131 tositumomab in patients with recurrent non-Hodgkin's lymphoma (NHL) and extensive bone marrow involvement
Jodi V Mones, Morton Coleman, Lale Kostakoglu, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
March 30, 2023
Primary Effusion Lymphoma in an HIV-Negative Patient with Chronic Myeloid Leukemia Treated with Dasatinib
Ivo N SahBandar, Chandler B Sy, Tayler van den Akker, et al.
Page
of 18
Search research articles
Search
Showing results (81-90 of 172) with videos related to
Sort By:
Page
of 18
Proceedings of the National Academy of Sciences of the United States of America
|
June 25, 2009
BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma
Masumichi Saito, Urban Novak, Erich Piovan, et al.
Blood
|
March 31, 2021
Synergistic efficacy of the dual PI3K-δ/γ inhibitor duvelisib with the Bcl-2 inhibitor venetoclax in Richter syndrome PDX models
Andrea Iannello, Nicoletta Vitale, Silvia Coma, et al.
Blood
|
April 2, 2015
The tumor virus landscape of AIDS-related lymphomas
Aaron Arvey, Akinyemi I Ojesina, Chandra Sekhar Pedamallu, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
September 17, 2020
Autopsy Findings in 32 Patients with COVID-19: A Single-Institution Experience
Sarah S Elsoukkary, Maria Mostyka, Alicia Dillard, et al.
Immunity
|
June 16, 2007
Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL
Bing He, Weifeng Xu, Paul A Santini, et al.
The Journal of Experimental Medicine
|
June 3, 2009
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
Till Strowig, Cagan Gurer, Alexander Ploss, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 1, 2010
Response to second-line therapy defines the potential for cure in patients with recurrent diffuse large B-cell lymphoma: implications for the development of novel therapeutic strategies
Rebecca L Elstrom, Peter Martin, Katya Ostrow, et al.
The Journal of Biological Chemistry
|
November 19, 2020
Targeted reduction of cholesterol uptake in cholesterol-addicted lymphoma cells blocks turnover of oxidized lipids to cause ferroptosis
Jonathan S Rink, Adam Yuh Lin, Kaylin M McMahon, et al.
Leukemia & Lymphoma
|
February 28, 2007
Dose-attenuated radioimmunotherapy with tositumomab and iodine 131 tositumomab in patients with recurrent non-Hodgkin's lymphoma (NHL) and extensive bone marrow involvement
Jodi V Mones, Morton Coleman, Lale Kostakoglu, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
March 30, 2023
Primary Effusion Lymphoma in an HIV-Negative Patient with Chronic Myeloid Leukemia Treated with Dasatinib
Ivo N SahBandar, Chandler B Sy, Tayler van den Akker, et al.
Page
of 18